Report: Bausch and Lomb could be sold for $9-billion
Posted at: 05/24/2013 4:45 PM
The Wall Street Journal is reporting Bausch and Lomb could be sold as soon as next week.
The newspaper quotes people close to the issue saying generic drug maker Valeant Pharmaceuticals international could buy it for $9-billion.
Bausch and Lomb’s owner, Warburg Pincus LLC, indicated at the beginning of the year it was entertaining take over offers for the eye care business.